Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  GlaxoSmithKline plc    GS7   GB0009252882

Real-time Quote. Real-time Tradegate - 01/28 01:33:17 am
20.131 EUR   +0.75%
01/27DJNovartis Upbeat Despite Weaker Profit -- 2nd Update
01/27 Novartis flags faster sales and profit growth for 2015
01/27DJNovartis Upbeat Despite Weaker Profit -- Update
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo GlaxoSmithKline plc
Develops, manufactures and distributes vaccines and other pharmaceutical products

GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.

It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare.

The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases.

The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis.

The Consumer Healthcare business markets a range of consumer health products based on scientific innovation.

The company was founded on December 6, 1999 and is headquartered in Brentford, the United Kingdom.
Managers
NameAgeSinceTitle
Andrew Philip Witty492008Chief Executive Officer & Executive Director
Christopher Charles Gent652004Non-Executive Chairman
Simon Dingemans502011Chief Financial Officer & Executive Director
William C. Louv, PhD--Chief Information Officer
James Samuel Shannon, MD582012Chief Medical Officer
Deryck Charles Maughan662004Senior Independent Non-Executive Director
Tom de Swaan682006Independent Non-Executive Director
Stephanie A. Burns, PhD592007Independent Non-Executive Director
Moncef Slaoui, PhD652006Executive Director & Chairman-Vaccines Division
Daniel K. Podolsky, PhD602006Independent Non-Executive Director
Shareholders
NameShares%
BlackRock Investment Management (UK) Ltd. 184,340,3133.79%
Invesco Asset Management Ltd. 178,053,3543.66%
Legal & General Investment Management Ltd. 162,498,9273.34%
Norges Bank Investment Management 99,086,0002.04%
BlackRock Advisors LLC 98,837,1382.03%
Aberdeen Asset Investments Ltd. 83,717,6561.72%
The Vanguard Group, Inc. 74,007,0001.52%
Schroder Investment Management Ltd. 70,402,3701.45%
M&G Investment Management Ltd. 64,214,9011.32%
GlaxoSmithKline Employee Trust 63,613,5281.31%
Holdings
NameShares%Valuation
Aspen Pharmacare Holdings Limited (APNJ) 56,570,78012.4%2,048,459,623 USD
Genmab A/S (GEN) 4,471,2027.85%221,511,306 USD
GlaxoSmithKline S.A.E. 76,161,37891.2%137,835,339 USD
Theravance Biopharma Inc (TBPH) 8,299,21825.8%131,293,629 USD
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSM) 444,065,54146.4%129,329,648 USD
Dong-A Socio Holdings Co Ltd (000640) 409,6939.14%46,406,852 USD
GALAPAGOS (GLPG) 508,6441.68%8,205,267 USD
Allergy Therapeutics plc (AGY) 10,118,0002.47%3,367,169 USD
Response Genetics, Inc. (RGDX) 5,000,00012.9%2,550,000 USD
Serendex Pharmaceuticals A/S 98,0100.65%126,327 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
NOVARTIS AG
ROCHE HOLDING LTD..
PFIZER INC.
MERCK & CO., INC.
SANOFI
BAYER AG
GLAXOSMITHKLINE P..
BRISTOL-MYERS SQU..
NOVO NORDISK A/S
ELI LILLY AND CO
ACTAVIS PLC
ALLERGAN, INC.
ABBOTT LABORATORI..
TEVA PHARMACEUTIC..
VALEANT PHARMACEU..
REGENERON PHARMAC..
SHIRE PLC
TAKEDA PHARMACEUT..
ASTELLAS PHARMA I..
Sector Pharmaceuticals
Company contact information
980 Great West road
TW8 9GS Brentford, Greater London
United Kingdom

Phone : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
Internet : http://www.gsk.com
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- Stoxx Europe 50 / FTSE 100, FTSE Eurotop 100, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- ISIN Code :  GB0009252882
- Bloomberg Code :  GSK:LN
- Reuters Code :  GSK.L
- Datastream Code :  GSK
© 2015 Factset    © 2015 Cofisem   
Dynamic quotes  
ON
| OFF